Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$12.52 – $18.50
100% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $346.0M | $400.8M | $408.1M | $571.4M | $673.6M | $692.3M | $565.8M | $590.6M |
| Cost of revenue | $214.2M | $248.2M | $272.2M | $365.3M | $430.1M | $440.2M | $327.0M | $459.1M |
| Gross profit | $131.9M | $152.5M | $135.9M | $206.1M | $243.5M | $252.1M | $238.8M | $131.6M |
| Gross margin | 38.1% | 38.1% | 33.3% | 36.1% | 36.1% | 36.4% | 42.2% | 22.3% |
| R&D | $16.2M | $15.0M | $16.1M | $19.8M | $19.9M | $0 | $0 | $0 |
| Operating income | $30.0M | $38.2M | $30.1M | $64.9M | $81.0M | $72.7M | $78.3M | $77.8M |
| EBITDA | $36.1M | $45.8M | $31.2M | $75.4M | $86.8M | $83.9M | $97.3M | $92.8M |
| Net income | $16.8M | $26.0M | $20.3M | $45.4M | $55.1M | $48.2M | $51.6M | $43.4M |
| Net margin | 4.9% | 6.5% | 5.0% | 8.0% | 8.2% | 7.0% | 9.1% | 7.3% |
| EPS (diluted) | 0.21 | 0.32 | 0.25 | 0.57 | 0.69 | 0.59 | 0.63 | 0.54 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $626M | $0.77 | $0.75–$0.78 | 1 |
| 2027 | $668M | $0.84 | $0.82–$0.86 | 1 |
Forward consensus · source: Financial Modeling Prep
EL. EN SPA ORD NEW
No one on the platform currently holds ELEAF.
No tracked institution reports a position in ELEAF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-26 | $0.2500 | 2026-05-27 |
| 2025-05-20 | $0.2200 | 2025-05-21 |
| 2024-05-20 | $0.2000 | 2024-05-22 |
| Execution date | Ratio |
|---|---|
| 2021-08-11 | 4-for-1 |
No one on the platform has traded ELEAF yet.
| $97176 |
| — |
| HGYMFHogy Medical Co.,Ltd. | $34.99 | +0.00% | $754M | — |
| INRLFValneva SE | $2.62 | +0.00% | $497M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.